Naoto Hirano

Dana-Farber Cancer Inst

$1,699,567

Attributed

$1,699,567

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $355.9K · FY2007–14

$500K$375K$250K$125K$0

'07

'08

'09

'10

'11

'12

'13

'14

Funding mix

By agency

NIH$1,699,567 · 2

By mechanism

R01$1,213,402 · 1

K22$486,165 · 1

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Kai W Wucherpfennig$37,935,181
Donald W. Kufe$50,160,456
Kenneth C Anderson$25,995,373
Ulrike S Eggert$2,581,362
Rani E George$9,003,170

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsTumor AntigensResponseBinding (Molecular Function)TrainingTumorGenerationsClinical TrialsLaboratoriesMetastatic MelanomaT-LymphocyteAntigen-Presenting CellsAntigensCancer PatientCancer TherapyCd4 Positive T LymphocytesCd8b1 GeneCell Culture SystemDesignIn VivoBaseCytotoxic T-LymphocytesAdoptive ImmunotherapyFight Against